[go: up one dir, main page]

ES8502105A1 - Un procedimiento para la preparacion de derivados de diben- zopirano - Google Patents

Un procedimiento para la preparacion de derivados de diben- zopirano

Info

Publication number
ES8502105A1
ES8502105A1 ES485619A ES485619A ES8502105A1 ES 8502105 A1 ES8502105 A1 ES 8502105A1 ES 485619 A ES485619 A ES 485619A ES 485619 A ES485619 A ES 485619A ES 8502105 A1 ES8502105 A1 ES 8502105A1
Authority
ES
Spain
Prior art keywords
preparation
amino
dibenzopyrans
pharmaceuticals
formulations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES485619A
Other languages
English (en)
Other versions
ES485619A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8502105A1 publication Critical patent/ES8502105A1/es
Publication of ES485619A0 publication Critical patent/ES485619A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE DIBENZOPIRANO.CONSISTE EN HACER REACCIONAR UN COMPUESTO (II) DONDE R1 ES HIDROGENO, R2 ES ALQUILO DE 5 A 10 ATOMOS DE CARBONO O ALQUENILO DE 5 A 10 GR DE CARBONO Y R3 ES HIDROGENO O METILO, CON UNA AMINA DE FORMULA H2NR4, PARA OBTENER UN COMPUESTO DE FORMULA GENERAL (I).APLICADO EN LA INDUSTRIA FARMACEUTICA PARA LA OBTENCION DE ANALGESICOS Y ANTIDEPRESIVOS.
ES485619A 1978-02-17 1979-11-01 Un procedimiento para la preparacion de derivados de diben- zopirano Granted ES485619A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/878,844 US4152450A (en) 1978-02-17 1978-02-17 9-Amino-dibenzopyrans

Publications (2)

Publication Number Publication Date
ES8502105A1 true ES8502105A1 (es) 1980-07-16
ES485619A0 ES485619A0 (es) 1980-07-16

Family

ID=25372961

Family Applications (4)

Application Number Title Priority Date Filing Date
ES477832A Expired ES477832A1 (es) 1978-02-17 1979-02-16 Un procedimiento para la preparacion de derivados de diben- zopirano.
ES485621A Expired ES485621A1 (es) 1978-02-17 1979-11-01 Un procedimiento para la preparacion de derivados de diben- zopirano
ES485620A Granted ES485620A0 (es) 1978-02-17 1979-11-01 Un procedimiento para la preparacion de derivados de diben- zopirano
ES485619A Granted ES485619A0 (es) 1978-02-17 1979-11-01 Un procedimiento para la preparacion de derivados de diben- zopirano

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES477832A Expired ES477832A1 (es) 1978-02-17 1979-02-16 Un procedimiento para la preparacion de derivados de diben- zopirano.
ES485621A Expired ES485621A1 (es) 1978-02-17 1979-11-01 Un procedimiento para la preparacion de derivados de diben- zopirano
ES485620A Granted ES485620A0 (es) 1978-02-17 1979-11-01 Un procedimiento para la preparacion de derivados de diben- zopirano

Country Status (29)

Country Link
US (1) US4152450A (es)
EP (1) EP0003883B1 (es)
JP (1) JPS54122278A (es)
AR (2) AR224359A1 (es)
AT (1) AT366039B (es)
AU (1) AU518718B2 (es)
BE (1) BE873981A (es)
CA (1) CA1111425A (es)
CH (1) CH638800A5 (es)
CS (1) CS207769B2 (es)
DD (1) DD142190A5 (es)
DE (1) DE2963797D1 (es)
DK (1) DK68179A (es)
ES (4) ES477832A1 (es)
FI (1) FI790503A7 (es)
FR (1) FR2417510A1 (es)
GB (1) GB2014571B (es)
GR (1) GR71465B (es)
HU (1) HU180729B (es)
IE (1) IE47999B1 (es)
IL (1) IL56582A0 (es)
LU (1) LU80922A1 (es)
NZ (1) NZ189591A (es)
PH (1) PH14622A (es)
PL (5) PL120661B1 (es)
PT (1) PT69202A (es)
RO (5) RO82369A (es)
SU (1) SU812177A3 (es)
ZA (1) ZA79726B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US4351833A (en) * 1980-07-28 1982-09-28 Pfizer Inc. 9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
US4870084A (en) * 1982-03-16 1989-09-26 Pfizer Inc. Bicyclic benzo fused pyran compounds used for nausea treatment and prevention
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US4863934A (en) * 1982-03-16 1989-09-05 Pfizer Inc. Bicyclic benzo fused pyran compounds used for producing analgesia
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4841078A (en) * 1982-03-16 1989-06-20 Pfizer Inc. Benzopyrans
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4680404A (en) * 1983-01-13 1987-07-14 Pfizer Inc. Benzopyrans
US5180736A (en) * 1989-03-23 1993-01-19 Warner-Lambert Company Polycyclic amines useful as cerebrovascular agents
US20010009965A1 (en) * 1998-05-04 2001-07-26 Alexandros Makriyannis Novel analgesic and immunomodulatory cannabinoids
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US7119108B1 (en) * 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6900236B1 (en) * 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
AU778159B2 (en) 1999-10-18 2004-11-18 University Of Connecticut, The Peripheral cannabinoid receptor (CB2) selective ligands
EP1361876A4 (en) * 2001-01-26 2004-03-31 Univ Connecticut NEW CANNABIMIMETIC LIGANDS
WO2002060447A1 (en) 2001-01-29 2002-08-08 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
AU2002320430A1 (en) * 2001-07-13 2003-01-29 University Of Connecticut Novel bicyclic and tricyclic cannabinoids
US7666867B2 (en) * 2001-10-26 2010-02-23 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
US7183313B2 (en) 2002-08-23 2007-02-27 University Of Connecticut Keto cannabinoids with therapeutic indications

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3676462A (en) * 1970-01-08 1972-07-11 Little Inc A 7,8,9,10-TETRAHYDRO (AND 7,8,9,10,11,12-HEXAHYDRO) 6H-DIBENZO {8 b,d{9 {0 PYRANS
US3649650A (en) * 1970-02-13 1972-03-14 Little Inc A Novel derivatives of tetrahydro-cannabinol
AU7612874A (en) * 1973-12-27 1976-06-10 Erba Carlo Spa Benzopyran derivatives

Also Published As

Publication number Publication date
ES8502106A1 (es) 1980-07-16
ES485621A1 (es) 1980-07-01
IL56582A0 (en) 1979-05-31
SU812177A3 (ru) 1981-03-07
ZA79726B (en) 1980-10-29
IE790304L (en) 1979-08-17
AU4398379A (en) 1979-08-23
RO82370A (ro) 1983-08-03
CH638800A5 (fr) 1983-10-14
PL121009B1 (en) 1982-04-30
PL213479A1 (es) 1980-03-10
GB2014571A (en) 1979-08-30
AR224359A1 (es) 1981-11-30
BE873981A (fr) 1979-08-07
PL120658B1 (en) 1982-03-31
HU180729B (en) 1983-04-29
ATA123979A (de) 1981-07-15
ES477832A1 (es) 1980-04-01
LU80922A1 (fr) 1979-06-18
EP0003883A1 (en) 1979-09-05
PL120661B1 (en) 1982-03-31
RO82375A (ro) 1983-08-03
DE2963797D1 (en) 1982-11-11
RO82376B (ro) 1983-07-30
US4152450A (en) 1979-05-01
GR71465B (es) 1983-05-30
ES485620A0 (es) 1980-07-16
AT366039B (de) 1982-03-10
RO82369A (ro) 1983-08-03
IE47999B1 (en) 1984-08-22
FR2417510B1 (es) 1980-08-14
CA1111425A (en) 1981-10-27
ES485619A0 (es) 1980-07-16
RO82370B (ro) 1983-07-30
RO82376A (ro) 1983-08-03
PT69202A (en) 1979-03-01
AU518718B2 (en) 1981-10-15
PL120645B1 (en) 1982-03-31
PL118576B1 (en) 1981-10-31
PH14622A (en) 1981-10-12
DD142190A5 (de) 1980-06-11
FR2417510A1 (fr) 1979-09-14
EP0003883B1 (en) 1982-10-06
RO82369B (ro) 1983-07-30
RO76886A (ro) 1982-02-01
NZ189591A (en) 1980-10-08
JPS54122278A (en) 1979-09-21
CS207769B2 (en) 1981-08-31
AR225939A1 (es) 1982-05-14
FI790503A7 (fi) 1979-08-18
GB2014571B (en) 1982-11-17
DK68179A (da) 1979-09-17

Similar Documents

Publication Publication Date Title
ES485621A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
CA2033392A1 (en) A-nor-steroid-3-carboxylic acid derivatives
ES2070660A1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
PT82127A (en) Process for the preparation of phenyl carbamates
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
DK0380063T3 (da) 1,2-Cyclohexylaminoarylamider til anvendelse som analgetika
MY136249A (en) Phenylethanolamine compounds as anti-obesity agents
ES8406477A1 (es) Procedimiento para la preparacion de b-carbolinas
AU588837B2 (en) Polypeptide
JPS53119844A (en) Optically active amino acid-mandelic acid complexes and theire preparation
GB8530602D0 (en) Heterocyclic compounds
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
IL75978A (en) Antiprotozoal and antifungal compositions containing vinyl isoquinoline derivatives,certain such novel compounds and their preparation
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
IL111791A0 (en) Glutaramide derivatives
ES8602676A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
ES8304923A1 (es) Un procedimiento para la preparacion de un peptido.
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
JPS55108883A (en) Ethyl-(gamma-acetamino-gamma-ethoxycarbonyl-gamma-cyanopropyl- methyl) phosphinate and its preparation
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.